FLUTEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flutex, and what generic alternatives are available?
Flutex is a drug marketed by Ivax Pharms and is included in four NDAs.
The generic ingredient in FLUTEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flutex
A generic version of FLUTEX was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUTEX?
- What are the global sales for FLUTEX?
- What is Average Wholesale Price for FLUTEX?
Summary for FLUTEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,287 |
DailyMed Link: | FLUTEX at DailyMed |
US Patents and Regulatory Information for FLUTEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivax Pharms | FLUTEX | triamcinolone acetonide | CREAM;TOPICAL | 085539-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Pharms | FLUTEX | triamcinolone acetonide | OINTMENT;TOPICAL | 087375-001 | Nov 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Pharms | FLUTEX | triamcinolone acetonide | CREAM;TOPICAL | 085539-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Pharms | FLUTEX | triamcinolone acetonide | CREAM;TOPICAL | 085539-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |